USTEKINUMAB USTEKINUMAB (13789R) ustekinumab 90 mg/mL injection, 1 mL syringe 13789R Body System: Antineoplastic And Immunomodulating Agents > Immunosuppressants > Immunosuppressants Manner of administration:Injection General Schedule Authority Required Restriction Indication: Complex refractory Fistulising Crohn disease Treatment phase: Continuing treatment Quantities & Cost Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge Max qty packs: 1 Max qty units: 1 # of repeats: 1 DPMQ: $986.28 Max safety net: $25.00 General Patient Charge: $25.00 Available brands Stelara Steqeyma Wezlana
